Tolerability of mycophenolate mofetil in elderly kidney transplant recipients: A retrospective cohort study.

Stephanie WitekGregory MalatDeirdre L SawinskiChelsea SammonsChristopher LaFratteAbigail ForteRahul SamudralwarSandra LyleJamal RashidJennifer Trofe-Clark

Published in: Clinical transplantation (2022)

Mycophenolate mofetil 1 g/day was poorly tolerated in both elderly and nonelderly KTRs receiving lymphocyte-depleting induction with a high incidence of dose reductions; however, no short-term adverse graft outcomes were identified.

Keyphrases

middle aged
community dwelling
risk factors
open label
peripheral blood
type diabetes
randomized controlled trial
adipose tissue
emergency department
insulin resistance
double blind
glycemic control